IndraLab

Statements


| 6 17

sparser
"The compound OTUB2-IN1-1 inhibits the deubiquitinase activity of OTUB2 without affecting the physical interaction between OTUB2 and PD-L1."

reach
"OTUB2 directly bound to PD-L1, hindering its ubiquitination and subsequent degradation within the endoplasmic reticulum."

reach
"Next, we characterized the interaction between OTUB2 and PD-L1."

reach
"To ensure that the ability of OTUB2-IN-1 to reduce PD-L1 expression was due to the impaired deubiquitinase activity of OTUB2 rather than the impaired binding of OTUB2 to PD-L1, we further verified the ability of OTUB2-IN-1 to block the binding of OTUB2 to PD-L1 using a blocking chemiluminescence immunoassay (CLIA) and a co-IP assay."

reach
"We found that OTUB2-IN-1 did not interfere with protein interactions between OTUB2 and PD-L1 (Fig. 9g and Supplementary Fig. 21)."

reach
"The effects of OTUB2-IN-1 on blocking the interactions between OTUB2 and PD-L1 was determined by an indirect CLIA."

reach
"To detect the interaction between OTUB2 and PD-L1, we used a Duolink® in situ PLA kit (Sigma‒Aldrich, DUO92101)."

sparser
"OTUB2 directly bound to PD-L1, hindering its ubiquitination and subsequent degradation within the endoplasmic reticulum."

sparser
"Mechanistically, OTUB2 directly interacts with PD-L1 to disrupt the ubiquitination and degradation of PD-L1 in the endoplasmic reticulum."

sparser
"An inhibitor of OTUB2, interfering with its deubiquitinase activity without disrupting the OTUB2-PD-L1 interaction, successfully reduces PD-L1 expression in tumor cells and suppressed tumor growth."

sparser
"OTUB2 interacts with PD-L1 in the ER and to disrupt the ERAD of PD-L1 to impair T-lymphocyte-mediated antitumor immunity."

sparser
"OTUB2 interacts with the intracellular domain (ICD) of PD-L1."

sparser
"In line with this result, ectopically expressed OTUB2 associated with PD-L1 in HEK293T cells (Fig.  xref ), and E . coli -purified OTUB2 interacted with PD-L1 in vitro (Fig.  xref and Supplementary Fig.  xref )."

sparser
"Ectopically expressed OTUB2-WT but not catalytically inactive OTUB2 (C51S mutant) associated with PD-L1 in HEK293T cells (Fig.  xref )."

sparser
"We also observed that endogenous OTUB2 interacted with PD-L1 in multiple cell lines by using primary antibodies against either OTUB2 or PD-L1 (Fig.  xref and Supplementary Fig.  xref )."

sparser
"To determine the subcellular location of the OTUB2-PD-L1 interacting complexes, we performed a Duolink in situ proximity ligation assay (PLA) and observed that the PLA signals were localized mainly in the cytoplasm (Fig.  xref and Supplementary Fig.  xref )."

sparser
"Next, we characterized the interaction between OTUB2 and PD-L1."

sparser
"To further explore the cellular location at which OTUB2 prevents the proteasomal degradation of PD-L1, we performed immunofluorescence (IF) following Duolink in situ PLAs using antibodies targeting different organelles to confirm the subcellular location of the OTUB2PD-L1 interaction."

sparser
"The PLA showed that PLA signals representing the OTUB2-PD-L1 interaction were mainly localized in the ER (Fig.  xref )."

sparser
"To ensure that the ability of OTUB2-IN-1 to reduce PD-L1 expression was due to the impaired deubiquitinase activity of OTUB2 rather than the impaired binding of OTUB2 to PD-L1, we further verified the ability of OTUB2-IN-1 to block the binding of OTUB2 to PD-L1 using a blocking chemiluminescence immunoassay (CLIA) and a co-IP assay."

sparser
"We found that OTUB2-IN-1 did not interfere with protein interactions between OTUB2 and PD-L1 (Fig.  xref and Supplementary Fig.  xref )."

sparser
"OTUB2 can interact with PD-L1 and deubiquitinate and stabilize the PD-L1 protein by intervening in the ERAD pathway."

sparser
"We demonstrated that OTUB2-IN-1 reduced PD-L1 protein turnover through inhibition of OTUB2 catalytic activity rather than blocking the OTUB2-PD-L1 interactions and exhibited strong growth-suppressive effects on multiple cancers by attenuating immunosuppression."